Advertisement
UK markets closed

  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     

  • HANG SENG

    17,763.03
    +16.12 (+0.09%)
     

  • CRUDE OIL

    79.13
    -2.80 (-3.42%)
     

  • GOLD FUTURES

    2,330.20
    +27.30 (+1.19%)
     

  • DOW

    37,903.29
    +87.37 (+0.23%)
     

  • Bitcoin GBP

    46,090.13
    -1,953.43 (-4.07%)
     

  • CMC Crypto 200

    1,202.07
    -136.99 (-10.23%)
     

  • NASDAQ Composite

    15,605.48
    -52.34 (-0.33%)
     

  • UK FTSE All Share

    4,418.60
    -11.65 (-0.26%)
     
Money:

Family finances

Who is the breadwinner in your family and does it matter?

United States Biopharmaceutical Third Party Logistics Markets Report 2021: Rising Demand for Temperature-controlled Logistic Services - Forecast to 2028

Research and Markets
·4-min read

Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "U.S. Biopharmaceutical Third Party Logistics Market Size, Share & Trends Analysis Report by Product Type (Specialty Drugs, Generics), by Supply Chain (Non-cold, Cold Chain), by Service Type, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

The U.S. biopharmaceutical third party logistics market size is expected to reach USD 62.3 billion by 2028, at a CAGR 7.1%

Increasing demand for novel biologics and the need to manage those is boosting the market growth. Moreover, the rising demand for temperature-controlled logistic services to transport biologics in various regions and the growing distribution networks of biopharmaceutical companies to improve their sales are factors driving the market growth.

The COVID-19 pandemic has had a major impact on global logistics to some extent due to diminished air freight capacity and reduced workforce at warehouses and airports. The decisions of local authorities to shut down the logistic infrastructure, enforce movement restriction, or put in place additional requirements to suppress transmission of the virus have also impacted the logistic services. This has significantly hindered many supply operations.

The future seems lucrative for the market with the retraction of government regulations related to transportation and shelter-in-place mandates. A sudden surge in the demand for cold chain logistics was observed during the pandemic. Growth in the manufacture and distribution of the COVID-19 vaccine is expected throughout 2021.

For instance, in March 2021, FedEx Express started shipping the COVID19 vaccine for McKesson Corp. to centers all across the U.S. The company has already shipped millions of COVID-19 vaccines since mid-December 2020.

U.S. Biopharmaceutical 3PL Market Report Highlights

  • The non-cold chain logistics held the largest market share of 80.8% in 2020 owing to the sales of a large number of drugs that do not require any temperature control

  • The cold chain logistics segment is projected to witness the fastest of CAGR 10.1% over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits

  • The increasing demand for the COVID-19 vaccine is a major contributing factor to the market growth. Furthermore, the rising trend of outsourcing logistics services is fueling the growth

  • The warehousing & storage segment held the largest revenue share of 43.6% in 2020 due to the growing demand for storage

  • The specialty drugs segment dominated the market in 2020 owing to the rapid growth in specialty pharma

ADVERTISEMENT

Key Topics Covered:

Chapter 1. Methodology and Scope
1.1 Market Segmentation & Scope
1.2 Research Methodology
1.3 Information Procurement
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Model Details

Chapter 2. Executive Summary
2.1 Market Outlook

Chapter 3. Market Definition
3.1 By Supply Chain
3.2 By Services Type
3.3 By Product Type

Chapter 4. U.S. Biopharmaceutical Third-Party Logistics Market: Variables, Trends, & Scope
4.1 Market Segmentation and Scope
4.2 Market Driver Analysis
4.2.1 Technological Advancements in Logistics
4.2.2 Growing Applications of Reverse Logistics in Biopharmaceutical Industry
4.2.3 Rising Demand for Cold Chain Logistics
4.3 Market Restraint Analysis
4.3.1 Compliance Issues while Outsourcing
4.4 Penetration & Growth Prospect Mapping
4.5 Porter's Five Forces Analysis
4.6 PESTEL Analysis

Chapter 5. Qualitative Information for Hub Services, Copay, and Adherence
5.1 Hub Services
5.2 Copay
5.3 Adherence

Chapter 6. U.S. Biopharmaceutical Third-Party Logistics Market: Supply Chain Segment Analysis
6.1 U.S. Biopharmaceutical Third-Party Logistics Market: Market Share Analysis, 2020 & 2028
6.2 Cold Chain Logistics
6.3 Non-Cold Chain Logistics

Chapter 7. U.S. Biopharmaceutical Third-Party Logistics Market: Services Type Segment Analysis
7.1 U.S. Biopharmaceutical Third-Party Logistics Market: Market Share Analysis, 2020 & 2028
7.2 Transportation
7.2.1 Transportation Market, 2016 - 2028 (USD Billion)
7.2.2 Air Freight
7.2.3 Sea Freight
7.2.4 Overland Transportation
7.3 Warehousing and Storage

Chapter 8. U.S. Biopharmaceutical Third-Party Logistics Market: Product Type Segment Analysis
8.1 U.S. Biopharmaceutical Third-Party Logistics Market: Market Share Analysis, 2020 & 2028
8.2 Specialty Drugs
8.3 Generics
8.4 Plasma Derived Products

Chapter 9. Company Profiles

  • Agility

  • Amerisourcebergen Corporation

  • Db Schenker

  • Dhl International Gmbh

  • Fedex

  • Kerry Logistics Network Limited

  • Kuehne + Nagel

  • Sf Express

  • United Parcel Service Of America, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/r2ju6s

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900